Safety pharmacological study of the compound of diphenhydramine hydrochloride and caffeine
10.12206/j.issn.1006-0111.202105115
- VernacularTitle:盐酸苯海拉明/咖啡因复方的安全药理学研究
- Author:
Lijun REN
1
;
Jing GU
1
;
Wenjing SHI
1
;
Ruina WANG
2
;
Xiaofang ZHANG
1
;
Jikuai CHEN
1
Author Information
1. Department of Hygiene and Toxicology, School of Naval Medicine.
2. Center for Drug Discovery and Development, School of Pharmacy, Naval Medical University, Shanghai 200433, China.
- Keywords:
compound of diphenhydramine hydrochloride and caffeine;
safety pharmacology;
nervous system;
cardiovascular system;
respiratory system
- From:
Journal of Pharmaceutical Practice
2022;40(3):238-242
- CountryChina
- Language:Chinese
-
Abstract:
Objective To provide the reference resource for the safe clinical use of the compound of diphenhydramine hydrochloride and caffeine by observing its effects on the nervous system, cardiovascular system and respiratory system in experimental animals. Methods Single dose of the compound of diphenhydramine hydrochloride and caffeine was given to animals orally. The effects on climbing ability of mice and blood pressure, electrocardiogram, respiration rate and amplitude in beagle dogs were observed and recorded. Results With the dosage of the compound of diphenhydramine hydrochloride and caffeine (diphenhydramine hydrochloride / caffeine ratio is 1/2.4) at 51, 102, 204 mg/kg, there was no significant effect on the climbing ability in mice. With the dosages of 14.2, 28.3, 56.6 mg/kg for male Beagle dogs and 5.66, 14.2, 28.3 mg/kg for female Beagle dogs, no significant effects were observed in systolic blood pressure, diastolic blood pressure, mean arterial pressure, heart rate, ECG（P wave, R wave , T wave, QRS time, PR interval, QT interval）, respiratory rate and amplitude. Conclusion Under the experimental conditions, single oral dose of the compound of diphenhydramine hydrochloride and caffeine has no significant effect on the nervous system, cardiovascular system and respiratory system in experimental animals. Those results suggest that the compound of diphenhydramine hydrochloride and caffeine is a safe agent for clinical use.
